Literature DB >> 10990232

On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999.

J Braun1, G Kingsley, D van der Heijde, J Sieper.   

Abstract

OBJECTIVE: There is no agreement on how to classify and diagnose reactive arthritis (ReA) and it is also unclear what kind of specific clinical and laboratory investigations are appropriate. We define relevant points of agreement and identify points of disagreement among an international group of experts in the field.
METHODS: Prior to the 4th International Workshop on Reactive Arthritis, Berlin, July 1999, we sent questionnaires to 42 experts identified by personal knowledge and recent publications.
RESULTS: The response rate was 81% (n = 34). There was agreement on the nomenclature and recommendation to use the term "reactive arthritis" only if the clinical picture and the microbes involved are HLA-B27 and spondyloarthropathy (SpA) associated, whereas the term "infection related arthritis" is used for all other arthritides related to or associated with infections. A differentiation between acute and chronic ReA with a cutoff of 6 months is recommended. The history of a preceding symptomatic infection is thought to be most relevant for a diagnosis of ReA. The minimal interval between preceding symptoms and arthritis is proposed to be 1-7 days, maximally 4 weeks. The joint pattern in ReA is asymmetrical, with predominance of the lower limbs. SpA related symptoms may contribute to the diagnosis. A search for chlamydia in urine/urethra/cervix is recommended, while in the case of diarrhea enterobacteria should be searched for in stool and antibodies against them in serum. There were also areas of disagreement, such as: Is arthritis essential for the diagnosis of ReA?, Is it oligoarthritis or any arthritis?, What are the role and value of polymerase chain reaction investigation?, The role and value of serology?, Is the diagnostic sensitivity of microbiological tests for ReA increased by HLA-B27 determination?
CONCLUSION: The points of agreement will support better communication in this area, and clarification of the disagreements will lead to further studies and discussion.

Entities:  

Mesh:

Year:  2000        PMID: 10990232

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  45 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 2.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection.

Authors:  Miroslav Harjacek; Jelena Ostojic; Oktavija Djakovic Rode
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

4.  [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis].

Authors:  V Krenn; L Morawietz; G-R Burmester; T Häupl
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

Review 5.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

Review 6.  Synthetic oligonucleotides as modulators of inflammation.

Authors:  Dennis Klinman; Hidekazu Shirota; Debra Tross; Takashi Sato; Sven Klaschik
Journal:  J Leukoc Biol       Date:  2008-04-22       Impact factor: 4.962

7.  [Low-grade-/high-grade-synovitis: synovitis-score as a gold standard?].

Authors:  V Krenn; L Morawietz; B König; M Otto; J Kriegsmann; A Köpenik; T Böhme; T Häupl
Journal:  Orthopade       Date:  2006-08       Impact factor: 1.087

8.  Epidemiology: Time to revisit the concept of reactive arthritis.

Authors:  Ramnath Misra; Latika Gupta
Journal:  Nat Rev Rheumatol       Date:  2017-05-11       Impact factor: 20.543

Review 9.  Reactive arthritis: developments and challenges in diagnosis and treatment.

Authors:  Davina Morris; Robert D Inman
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

10.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.